Mineralys Therapeutics, Inc.
MLYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37 | -$43 | -$42 | -$49 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $5 | $4 | $3 |
| Change in WC | $5 | $11 | -$6 | -$20 |
| Other Non-Cash | -$2 | -$2 | -$1 | -$1 |
| Operating Cash Flow | -$29 | -$30 | -$45 | -$67 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$301 | -$118 | -$128 | -$64 |
| Inv. Sales/Matur. | $150 | $75 | $35 | $148 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$151 | -$43 | -$93 | $84 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $289 | $10 | $189 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $0 | $0 | $0 |
| Financing Cash Flow | $295 | $10 | $189 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $116 | -$63 | $51 | $17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102 | $165 | $114 | $97 |
| End Cash | $218 | $102 | $165 | $114 |
| Free Cash Flow | -$29 | -$30 | -$45 | -$67 |